Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Fuchs

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cells|September 5, 2020
Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated DeliveryNatalie Fuchs, Mergim Meta, Detlef Schuppan, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 1, 2025
TREM2 hit discovery using temperature-related intensity change (TRIC) technology: A proof-of-concept high-throughput screening approachNatalie Fuchs, Katarzyna Kuncewicz, Farida El Gaamouch, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
TREM2 Hit Discovery Using TRIC Technology: A Proof-of-Concept High-Throughput Screening ApproachNatalie Fuchs, Katarzyna Kuncewicz, Farida El Gaamouch, et al.
Journal of Personalized Medicine|January 22, 2024
Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based ApproachesNatalie Fuchs, Longfei Zhang, Laura Calvo-Barreiro, et al.
Bioorganic & Medicinal Chemistry|March 7, 2026
High-throughput fragment screening identifies a new small molecule scaffold that modulates TREM2 SignalingNatalie Fuchs, Farida El Gaamouch, Hossam Nada, et al.
Biorxiv : the Preprint Server for Biology|December 8, 2025
High-Throughput Fragment Screening Identifies a New Small Molecule Scaffold that Modulates TREM2 SignalingNatalie Fuchs, Farida El Gaamouch, Hossam Nada, et al.
ACS Medicinal Chemistry Letters|June 19, 2024
Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and PermeabilityMergim Meta, Collin Zimmer, Natalie Fuchs, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-3Natalie Fuchs, Laura Calvo-Barreiro, Valerij Talagayev, et al.
Engineering in Life Sciences|May 12, 2021
Applicability of a single-use bioreactor compared to a glass bioreactor for the fermentation of filamentous fungi and evaluation of the reproducibility of growth in pellet formWinda Soerjawinata, Konstantin Schlegel, Natalie Fuchs, et al.
Chemmedchem|May 24, 2023
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in CancerNatalie Fuchs, Mergim Meta, Bellinda Lantzberg, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cells|September 5, 2020
Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated DeliveryNatalie Fuchs, Mergim Meta, Detlef Schuppan, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 1, 2025
TREM2 hit discovery using temperature-related intensity change (TRIC) technology: A proof-of-concept high-throughput screening approachNatalie Fuchs, Katarzyna Kuncewicz, Farida El Gaamouch, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
TREM2 Hit Discovery Using TRIC Technology: A Proof-of-Concept High-Throughput Screening ApproachNatalie Fuchs, Katarzyna Kuncewicz, Farida El Gaamouch, et al.
Journal of Personalized Medicine|January 22, 2024
Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based ApproachesNatalie Fuchs, Longfei Zhang, Laura Calvo-Barreiro, et al.
Bioorganic & Medicinal Chemistry|March 7, 2026
High-throughput fragment screening identifies a new small molecule scaffold that modulates TREM2 SignalingNatalie Fuchs, Farida El Gaamouch, Hossam Nada, et al.
Biorxiv : the Preprint Server for Biology|December 8, 2025
High-Throughput Fragment Screening Identifies a New Small Molecule Scaffold that Modulates TREM2 SignalingNatalie Fuchs, Farida El Gaamouch, Hossam Nada, et al.
ACS Medicinal Chemistry Letters|June 19, 2024
Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and PermeabilityMergim Meta, Collin Zimmer, Natalie Fuchs, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-3Natalie Fuchs, Laura Calvo-Barreiro, Valerij Talagayev, et al.
Engineering in Life Sciences|May 12, 2021
Applicability of a single-use bioreactor compared to a glass bioreactor for the fermentation of filamentous fungi and evaluation of the reproducibility of growth in pellet formWinda Soerjawinata, Konstantin Schlegel, Natalie Fuchs, et al.
Chemmedchem|May 24, 2023
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in CancerNatalie Fuchs, Mergim Meta, Bellinda Lantzberg, et al.
Pageof 2